Q3 2025 Holdings
Filed 2025-11-14 | 40 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $145.4M | 3,904,456 | 14.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $116.8M | 661,388 | 11.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $98.1M | 4,175,542 | 9.5% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $63.3M | 3,705,750 | 6.2% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $62.7M | 15,666,731 | 6.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $58.8M | 5,023,385 | 5.7% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $48.5M | 926,799 | 4.7% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $45.3M | 4,693,389 | 4.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $35.5M | 747,818 | 3.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $34.0M | 3,678,394 | 3.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $33.7M | 1,387,559 | 3.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $31.7M | 2,209,118 | 3.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $25.1M | 8,253,316 | 2.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $22.5M | 1,299,022 | 2.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $21.7M | 1,473,136 | 2.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $20.2M | 742,017 | 2.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $19.2M | 6,300,644 | 1.9% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $16.2M | 12,872,946 | 1.6% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $14.3M | 552,594 | 1.4% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $13.2M | 5,539,724 | 1.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $11.7M | 1,899,342 | 1.1% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $11.2M | 2,164,777 | 1.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $11.2M | 3,031,009 | 1.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $8.7M | 552,506 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.5M | 327,008 | 0.8% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $6.3M | 441,701 | 0.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $6.1M | 777,178 | 0.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.1M | 3,332,983 | 0.6% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $5.3M | 129,364 | 0.5% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $5.0M | 435,239 | 0.5% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $3.7M | 451,099 | 0.4% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.3M | 1,073,386 | 0.3% |
| Lava Therapeutics NV | SHS | N51517105 | $3.2M | 2,074,372 | 0.3% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $2.8M | 1,586,174 | 0.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.5M | 2,285,320 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.4M | 1,591,695 | 0.2% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $2.2M | 535,818 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $482.6K | 87,118 | 0.0% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $479.5K | 82,955 | 0.0% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $301.9K | 245,458 | 0.0% |